← Back to Search

Vaccine Norms Feedback for Vaccine Hesitancy

N/A

Recruiting

Led By Scott Graupensperger, PhD

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will use an online intervention to correct misperceived social norms related to vaccine hesitancy among young adults (18-25) in order to increase uptake & reduce time to first dose of the COVID-19 vaccine.

Who is the study for?

This trial is for young adults aged 18-24 in the US who haven't had a COVID-19 vaccine and are willing to participate. They must understand English well, pass attention checks during screening, and give their consent to be part of the study.

What is being tested?

The study tests an online intervention giving personalized feedback based on social norms to reduce vaccine hesitancy among young adults. Participants will be randomly assigned to receive this intervention or an attention-matched control, with follow-ups over six months.

What are the potential side effects?

Since this trial involves no medical treatments but rather informational feedback, there are no direct physical side effects expected from participating in the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

COVID-19 vaccine attitudes

COVID-19 vaccine uptake

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Vaccine Norms FeedbackExperimental Treatment1 Intervention

The participants in the treatment condition will receive personalized normative feedback (PNF) that entails correcting normative misperceptions for US young adults' vaccine uptake rates and prevalence of vaccine hesitancies (e.g., fear of side effects). Participants will be shown discrepancies between their perceived estimate of young adults' vaccination rates and actual national estimates derived from the US Census Bureau's Household Pulse Survey to highlight, in most cases, that they underestimated the vaccination norms.

Group II: Alcohol Norms FeedbackActive Control1 Intervention

Participants randomized to control will complete all measures at the same time as participants in the treatment condition, but will not receive any normative information regarding vaccines. Instead, to match for attention and provide potential benefit, those in the control condition will receive a standard dynamic norms feedback pertaining to alcohol use norms and behaviors.

Do I qualify?Apply below to find out